Found Medicare GLP-1 Bridge Review (2026): Zepbound and Wegovy at a $50 Copay
By Charly P. · Published August 9, 2026 · 12 min read
Found has built something the rest of the GLP-1 telehealth market has largely skipped: a program for adults aged 65 to 75 that runs branded medication through Medicare Part D instead of selling around it. The Medicare GLP-1 Bridge covers Zepbound®, Wegovy® or Foundayo™ at an advertised $50/month copay, with Found's team verifying your plan and filing the prior authorization before you pay anything. Add membership from $49/month and the total starts at $99/month — against roughly $650/month for branded Zepbound or Wegovy paid in cash. If you qualify, the math is not close.
Found Medicare GLP-1 Bridge at a Glance
| Program | Found Medicare GLP-1 Bridge |
|---|---|
| Who It Is For | Adults aged 65–75 with Medicare Part D drug coverage |
| Medication Copay | $50/month advertised (compared against $198/month) |
| Found Membership | From $49/month when billed annually |
| Total Starting Price | From $99/month; best price on the 12-month plan |
| Medications Covered | Zepbound®, Wegovy®, or Foundayo™ |
| Insurance | Runs through your existing Medicare Part D drug plan |
| Paperwork | Prior authorization filed and tracked by Found’s team |
| Eligibility Check | Free, about 3 minutes, no commitment |
| Clinician Review | Board-certified clinicians, 1–2 days |
| Ongoing Care | Monthly clinician check-ins, in-app side-effect support, messaging |
| Fulfillment | Licensed pharmacy, shipped to your door |
| Company Scale | 300,000+ members, 1.4M lbs lost, 4.89 average rating |
| Reported Results | ~12% average body weight loss at 1 year (1,773 tracked users) |
What Is the Found Medicare GLP-1 Bridge?
The Bridge is a distribution route, not a new drug. Found is a telehealth weight care platform — 300,000+ members, board-certified clinicians trained in obesity medicine, an app with tracking and a member community — and for most of its customers it sells either compounded GLP-1s from around $99/month or branded ones from around $650/month in cash. The Medicare Bridge is a fourth path built specifically for people on Part D, where the medication is billed to your existing drug plan and Found handles the administrative work that normally makes that impossible for an individual to pull off.
That administrative work is the actual product. Prior authorization for a GLP-1 is a documentation exercise: the plan wants a qualifying diagnosis, a clinical rationale, and often evidence of prior treatment, submitted in the format that plan expects. Found says its team files and tracks it start to finish, and verifies your plan before you pay anything. For a 68-year-old who has been quoted $650 a month at a pharmacy counter and told to take it up with their insurer, that is a meaningful thing to outsource. Our best weight loss treatments guide covers how the rest of the market prices the same medications without insurance in the picture.
Found also frames the clinical side for this age band specifically: at-home visits, and a plan designed around starting a GLP-1 later in life rather than a protocol written for a 35-year-old and reused. That is positioning rather than a documented separate protocol, but it points at something real — dose titration, muscle preservation and drug interactions all deserve more care at 70 than at 35.
How Medicare Part D Coverage Actually Works Here
This is the section to read twice, because it determines whether the $50 copay is available to you at all. Medicare Part D is barred by statute from covering drugs used for weight reduction. That exclusion has not been repealed, which is precisely why a program needs to exist to bridge the gap — and why the name is honest.
What Part D plans can cover is a GLP-1 prescribed for an approved indication that is not weight loss. Two of those now exist. Wegovy is FDA-approved to reduce the risk of cardiovascular death, heart attack and stroke in adults with established cardiovascular disease plus obesity or overweight — the FDA approved that indication after a trial in which major adverse cardiovascular events occurred in 6.5% of participants on Wegovy versus 8% on placebo. Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity, an approval the FDA granted in December 2024 as the first medication for OSA.
Read those two indications against the population this program targets and the design makes sense. Cardiovascular disease and sleep apnea are both common in adults aged 65 to 75 carrying excess weight, and many people in that band already have a documented diagnosis sitting in their chart. The clinician review is, among other things, establishing whether one applies to you. If neither does, Part D coverage is unlikely regardless of how well the paperwork is filed — and no telehealth platform can change that.
Found Medicare Bridge Pricing
Found splits the price into two visible lines, which is the right way to publish it — the medication and the service are billed by different parties and behave differently.
| Line Item | Cost | What It Covers |
|---|---|---|
| Medication copay | $50/month | Zepbound®, Wegovy® or Foundayo™ billed through your Part D plan |
| Found membership | From $49/month | Insurance paperwork, ongoing clinician support, prescription management |
| Total | From $99/month | Best rate requires the 12-month plan, billed annually |
Set that against what the same branded medications cost without coverage and the gap is the entire argument for this program. Found lists Wegovy and Zepbound from about $650/month in cash, with Ozempic and Mounjaro around $1,100/month. At $99/month all-in, the Bridge is roughly a sixth of the branded cash price for a medication that is FDA-approved rather than compounded — a distinction that matters, since compounded GLP-1s are not reviewed by the FDA for safety, quality or efficacy.
It is worth being clear about what the Bridge is not competing with. If you are shopping compounded semaglutide, providers like altRx advertise $89/month and HumeCare+ $199/month — comparable or cheaper monthly numbers with no insurance involved and no eligibility hurdle. The Bridge wins when you want the branded, FDA-approved drug and have a Part D plan that can be made to pay for most of it. That is a narrower case than the headline suggests, and a much better one when it fits.
How the Found Medicare Bridge Works
Four steps, entirely online, from eligibility check to medication at your door.
- 1.Take a 3-Minute Health Assessment
Found says the questions were built by the same licensed clinicians who review your case, and that by the end you will have a sense of which medication fits before checkout. This is also the free eligibility check — no commitment, and Found verifies your plan before you pay anything.
- 2.A Board-Certified Clinician Reviews Your Profile (1–2 Days)
A clinician, not an algorithm, evaluates whether GLP-1 medication is medically appropriate for you. For the Medicare route this review also establishes the clinical picture the prior authorization will rest on. If approved, your prescription is written.
- 3.Found Files the Paperwork and Your Medication Ships
Found’s team files and tracks the prior authorization with your Part D plan start to finish. Once approved, the medication is prepared by a licensed pharmacy and shipped to your door.
- 4.Ongoing Care That Adapts
Monthly clinician check-ins keep your dose optimized as you titrate. Refills are handled for you, side-effect support lives in the app, and you can message your care team between visits.
The Care Team
Found does something most telehealth platforms avoid: it names the clinicians and publishes their individual patient ratings. Every Found clinician is described as board-certified and trained in obesity care.
| Dr. Molly Middleton, MD | Family & obesity medicine — 4.93 patient rating |
|---|---|
| Dr. Jennifer Wetherington, MD | Family & lifestyle medicine — 4.91 patient rating |
| Kai Lehardi, NP | Family medicine — 4.87 patient rating |
| Gem Escamilla, NP | Family medicine — 4.85 patient rating |
Named clinicians with visible ratings are an accountability signal, and one that is easy for a competitor to copy and telling that so few do. Note that these are Found's own patient ratings rather than an independent registry, and that you will not necessarily be assigned any specific person on the list.
What Results Does Found Report?
Found publishes more outcome data than most of the category, and the figures are notably restrained — which, oddly, makes them more credible. Across 1,773 tracked users, average weight loss was about 12% of body weight over one year, with 83% of members sustaining results at one year and more than 80% reporting zero side effects on starting. Platform-wide it reports 300,000+ members, 1.4 million pounds lost and a 4.89 average rating.
The 12% figure sits below the 15–20% range reported in the pivotal trials for Wegovy and Zepbound at their highest doses, and Found says so itself rather than quoting the trial ceiling as an expected result. Real-world averages generally land under trial averages because adherence, titration pace and dose all vary outside a study protocol. A provider that publishes the lower real number is telling you something useful about how it sets expectations.
Found Medicare GLP-1 Bridge Pros and Cons
Pros
- ✓Branded, FDA-approved medication — Zepbound® and Wegovy®, not a compounded substitute
- ✓$50/month advertised medication copay against roughly $650/month cash for the same drugs
- ✓Total from $99/month including membership on the 12-month plan
- ✓Prior authorization filed and tracked by Found — the hardest part of Part D coverage, outsourced
- ✓Free eligibility and plan verification before you pay anything, in about 3 minutes
- ✓Program designed for the 65–75 age band rather than repurposed from a younger protocol
- ✓Named board-certified clinicians with published patient ratings, monthly check-ins
- ✓Company-reported results are restrained and specific (~12% at one year, 1,773 users tracked)
Cons
- ✗Narrow eligibility — ages 65–75 with active Medicare Part D coverage only
- ✗Part D cannot cover a GLP-1 for weight loss alone; coverage generally requires a qualifying diagnosis such as cardiovascular disease or obstructive sleep apnea
- ✗$50 is a starting copay — Found states coverage and copays vary by eligibility and insurance approval
- ✗The $99/month total assumes annual billing on a 12-month plan
- ✗Approval timing depends on your plan, so a start date can slip beyond the 1–2 day clinician review
- ✗Foundayo™ is Found’s own branded option rather than a manufacturer GLP-1 — ask what it contains
- ✗GLP-1 medications carry serious risks, including a boxed warning for thyroid C-cell tumors
How the Bridge Compares to Cash-Pay GLP-1 Programs
The right comparison depends entirely on whether you can use insurance. Here is how the Bridge lines up against three cash-pay routes we have reviewed:
| Route | Monthly Cost | Medication | Eligibility Hurdle |
|---|---|---|---|
| Found Medicare Bridge | From $99 all-in | Branded Zepbound®/Wegovy®, FDA-approved | |
| Found cash-pay branded | From ~$650 | Branded Zepbound®/Wegovy®, FDA-approved | |
| HumeCare+ | $199 semaglutide / $299 tirzepatide | Compounded, not FDA-approved | |
| altRx | $89 semaglutide / $149 tirzepatide | Compounded, not FDA-approved |
Two things fall out of that table. First, if you clear the eligibility bar, nothing else on the market gets you branded, FDA-approved medication near $99/month — the Bridge is not competing on price so much as occupying a lane by itself. Second, if you do not clear it, a compounded provider such as Measured will be cheaper and faster to start, at the cost of taking a product the FDA has not reviewed. Found's own oral GLP-1 program is a third option if injections are the sticking point, and the weight loss reviews hub covers the rest of the field.
Who Should Use the Found Medicare Bridge?
The clearest fit is someone aged 65 to 75 on Medicare Part D who has already been told a GLP-1 would help and has already discovered what it costs. If you have a cardiovascular diagnosis or diagnosed sleep apnea in your record alongside excess weight, you are close to the exact case this program was built around, and the free three-minute check costs you nothing to confirm.
It also fits someone who has been quietly avoiding the paperwork. Prior authorization is a genuine deterrent, and plenty of people who would qualify never find out because the process is opaque and the first denial ends the attempt. Having a team file and track it is worth the membership fee on its own for that reader.
Skip it in three cases: you are outside the 65–75 band, you have no Part D drug coverage, or weight loss is your only clinical indication and nothing else in your chart supports coverage. In any of those, a cash-pay compounded program will get you treated faster, and the 2026 weight loss treatment comparison is the better place to start.
Safety and Medical Oversight
Every prescription runs through a board-certified clinician trained in obesity care, with monthly check-ins to adjust dose and in-app side-effect support between visits. Because the Bridge dispenses branded Zepbound and Wegovy through a licensed pharmacy, you are getting an FDA-approved finished product with a full label — a meaningful safety advantage over compounded alternatives.
Bottom Line
Our Editorial Take
The Medicare GLP-1 Bridge is the most interesting thing Found has launched, because it solves a problem money alone cannot. Adults aged 65 to 75 are among the people most likely to benefit from a GLP-1 and least likely to be able to afford one out of pocket, and the barrier has never been the prescription — it has been the prior authorization. Found took the administrative burden onto itself and priced the result at $99/month all-in for branded, FDA-approved medication. Nothing else in this market does that.
The honest limit is eligibility. Medicare Part D still cannot cover a GLP-1 for weight loss alone, so the program works through the cardiovascular and sleep apnea indications the FDA has approved — which means your chart, not your intent, decides whether the $50 copay is available. Found is upfront that coverage and copays vary, and the free three-minute check gives you the answer without spending anything, which is the right way to structure a program with a real qualification gate.
Worth checking if you are 65 to 75 on Part D, particularly with a cardiovascular or sleep apnea diagnosis on file. Not worth pursuing if you fall outside the age band, lack Part D coverage, or have no qualifying indication — in those cases a cash-pay program will treat you faster. Read the refund policy and offer terms before committing to the 12-month plan that unlocks the $49 membership rate.
Key Program Details
| Website | joinfound.com |
|---|---|
| Eligibility Check | Free, about 3 minutes, no commitment |
| Age Range | 65–75 |
| Insurance Required | Active Medicare Part D drug coverage |
| Policies | Terms of Service, Refund Policy, Payment & Billing Consent, Telehealth Consent, Privacy Policy, Notice of Privacy Practices |
Found Alternatives
Not eligible for the Bridge, or want to compare before you check? Here are the top-rated GLP-1 weight loss programs we recommend:
Recommended Providers
Our editorial team’s top picks for this category.
Frequently Asked Questions
Recommended Providers
Our editorial team’s top picks for this category.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.